Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an ...

Legend Holdings Delivered Significant Recovery in 2024 PerformanceHONG KONG, Mar 28, 2025 - (ACN Newswire) - Legend Holdings Corporation ("Legend Holdings" or the "Company" Stock Code: 3396.HK) announ ...

Shai Biran; Investor Relations; Spero Therapeutics Inc. Esther Rajavelu; Interim President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer, Chief Business Officer; Spero ...

• A 2023 study found the average ROI for companies was $7 for every $1 spent on leadership development. Leadership development and accountability must be a fundamental part of your business strategy ...

Feeling busy but getting nowhere? This post reveals why attention-deficit/hyperactivity disorder makes productivity ...